Journals / Endoskopi / 2014 / Cilt: 22 - Sayı: 1

Comparison of esophageal cancer patients in the Erzurum region in two periods (2002-2004 and

Erzurum yöresi 2002-2004 ve 2010-2012 yıllarında saptanan özofagus kanserlerinin karşılaştırılması

Journal
Endoskopi
Pages
4–7
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mid-esophageal localization of tumors was higher in the 1st period (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Aims: Esophageal cancer is more common in the Eastern Anatolian region than in other regions.
📊
Key Findings & Data:Materials and Met- hods: Age, gender, tumor localization, and pathological diagnosis of patients with esophageal cancer seen in our unit from 2002-2004 (1st period) and from 2010- 2012 (2nd period) were compared retrospectively.
💡
Conclusion & Impact:Mid-esophageal localization of tumors was higher in the 1st period (p
🔬Design:Research Article
📍Scope:2002-2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Aims: Esophageal cancer is more common in the Eastern Anatolian region than in other regions. We aimed to compare patients de- tected to have esophageal cancer in the Erzurum Regional Training and Re- search Hospital, Endoscopy Unit, in two time periods. Materials and Met- hods: Age, gender, tumor localization, and pathological diagnosis of patients with esophageal cancer seen in our unit from 2002-2004 (1st period) and from 2010- 2012 (2nd period) were compared retrospectively. Localizations and histopathological features of esophageal lesions were evaluated accor- ding to the World Health Organization classification. Results: Among 79 patients with esophageal cancer seen in the 1st period, 41 were male (52%), the age range was 21-92 years, and the mean age at diagnosis was 60 years. In the 2nd period, 34 of 71 patients were male (48%), the age range was 38-87 years, and the mean age at diagnosis was 64 years. There were no sig- nificant differences in terms of age and gender distribution between the two periods (p>0,5). Mid-esophageal localization of tumors was higher in the 1st period (p

Özet

Bu çalışma 20-25 Kasım 2012, 29. Ulusal Gastroenteroloji Kongresinde sözlü bildiri olarak sunulmuştur.(%64). 2003-2009 arasındaki dönemde özofagus yassı epitel hücreli kanser ve gastrik kardiyak kanser insidansı artmıştır. Her iki kanser insidansı erkeklerde kadınlara göre daha yüksek bulunmuştur. Tüm subgruplarda sürvi kötü olup, 1 yıllık %45,9-%65,6, 5 yıllık %14,7-%30,5 arasındadır (6). 19982008 yılları arasında radyoterapinin tedavide kullanımı özellikle ilerlemiş orta ve distal özofagus kanserinde artmıştır. En iyi sağkalım cerrahi ve radyoterapinin birlikte kullanılması ile sağlanmaktadır (7). Özofagus adenokanser insidansı batı dünyasında hızlı bir şekilde artmaktadır. Obezite ve diğer hayat sitili ile ilgili faktörlerin bu artıştan sorumlu olduğu düşünülmektedir (8).Ülkemizde özofagus kanseri en sık Doğu Anadolu Bölgesinde görülmekte olup, bu bölgede endemiktir (9,10).Bu çalışmada Erzurum Bölge Eğitim ve Araştırma Hastanesi Endoskopi Ünitesinde bir dekat arayla iki farklı dönemde özofagus kanseri saptanan hastaların karşılaştırılması amaçlanmıştır.

🔖

Cite This Article

UYANIKOĞLU, A., COŞKUN, M., BİNİCİ, D. N. (2022). Comparison of esophageal cancer patients in the Erzurum region in two periods (2002-2004 and. Endoskopi, Cilt: 22 - Sayı: 1, 4–7. https://ajindex.com/articles/501148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013; 19:5598-606.
  2. Li WQ, Hu N, Wang Z, et al. Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. PLoS One 2013; 8:e68999. Navarro Silvera SA, Mayne ST, Gammon MD, et al. Diet and lifestyle fac- tors and risk of subtypes of esophageal and gastric cancers: classification tree analysis. Ann Epidemiol 2014; 24:50-7.
  3. Akbas H, Uyanikoglu A, Aydogan T, et al. E-Cadherin (CDH1) Gene- 160C>A promotor polymorphism and risk factor of gastric and esopha- geal cancers. Acta Medica Mediterranea 2013; 29:671. Dubecz A, Solymosi N, Stadlhuber RJ, et al. Does the incidence of ad- enocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis. J Gastrointest Surg 2013 Nov 15. [Epub ahead of print]. Liu SZ, Wang B, Zhang F, et al. Incidence, survival and prevalence of esophageal and gastric cancer in linzhou city from 2003 to 2009. Asian Pac J Cancer Prev 2013; 14:6031-4.
  4. Worni M, Castleberry AW, Gloor B, et al. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esoph- ageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esopha- gus 2013 Aug 13. [Epub ahead of print] Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and The Netherlands. Am J Gastroenterol 2014; 109:336-43; quiz 335, 344. Epub 2013 Dec 17. Uyanıkoğlu A, Coşkun M, Binici DN, et al. Doğu Anadolu Bölgesinde Üst GİS Kanseri Saptanan Hastaların Gastroskopi ve Biyopsi Sonuçları [Eastern Anatolia Region Gastroscopy and Biopsy of Patients with Gastrointestinal Cancer]. Dünya Gastroenteroloji Derneği Bölgesel Toplantısı ve 28. Ulusal Gastroenteroloji Haftası [WGO Regional Meet- ing With The 28th Turkish Gastroenterology Week]. 16-20 Kasım 2011, Antalya. Turk J Gastroenterol 2011; 22(Supp1): P-24, 129. Uyanıkoğlu A, Coşkun M, Binici DN, et al. Erzurum yöresi gastroskopi ve patoloji sonuçlarının değerlendirilmesi [Evaluation of gastroscopic and pathologic results Erzurum Region]. Türkiye Klinikleri J Gastroen- terohepatol 2011; 18:70-4.
  5. Mathieu LN, Kanarek NF, Tsai HL, et al. Age and sex differences in the incidence of esophageal adenocarcinoma: results from